Cargando…
Evidence-based medicine: Classifying the evidence from clinical trials – the need to consider other dimensions
The current approach to assessing the quality of evidence obtained from clinical trials focuses on three dimensions: the quality of the design (with double-blinded randomised controlled trials representing the highest level of such design); the statistical power (beta) and the level of significance...
Autores principales: | Bellomo, Rinaldo, Bagshaw, Sean M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751050/ https://www.ncbi.nlm.nih.gov/pubmed/17029653 http://dx.doi.org/10.1186/cc5045 |
Ejemplares similares
-
The need to reform our assessment of evidence from clinical trials: A commentary
por: Bagshaw, Sean M, et al.
Publicado: (2008) -
The implications of the PEPTIC trial for clinical practice
por: Young, Paul J., et al.
Publicado: (2023) -
Early acute kidney injury and sepsis: a multicentre evaluation
por: Bagshaw, Sean M, et al.
Publicado: (2008) -
Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units
por: Bagshaw, Sean M, et al.
Publicado: (2007) -
Clinical review: Volume of fluid resuscitation and the incidence of acute kidney injury - a systematic review
por: Prowle, John R, et al.
Publicado: (2012)